loadpatents
name:-0.011433839797974
name:-0.0053009986877441
name:-0.00054383277893066
Letourneau; Jeffrey John Patent Filings

Letourneau; Jeffrey John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Letourneau; Jeffrey John.The latest application filed is for "nitrogen heterocycle biaryls for osteoporosis and other diseases".

Company Profile
0.5.8
  • Letourneau; Jeffrey John - East Windsor NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Azinone and diazinone V3 inhibitors for depression and stress disorders
Grant 8,350,043 - Letourneau , et al. January 8, 2
2013-01-08
N-heterocyclic inhibitors of TNF-.alpha. expression
Grant 7,479,495 - Moriarty , et al. January 20, 2
2009-01-20
Nitrogen heterocycle biaryls for osteoporosis and other diseases
Grant 7,365,209 - Letourneau , et al. April 29, 2
2008-04-29
Nitrogen Heterocycle Biaryls For Osteoporosis And Other Diseases
App 20080051423 - Letourneau; Jeffrey John ;   et al.
2008-02-28
Azinone and diazinone V3 inhibitors for depression and stress disorders
App 20070037822 - Letourneau; Jeffrey John ;   et al.
2007-02-15
Pyrimidine kinase inhibitors
App 20050277642 - Erickson, Shawn David ;   et al.
2005-12-15
N-heterocyclic inhibitors of TNF-alpha expression
App 20050239770 - Moriarty, Kevin Joseph ;   et al.
2005-10-27
Nitrogen heterocycle biaryls for osteoporosis and other diseases
App 20050222203 - Letourneau, Jeffrey John ;   et al.
2005-10-06
Pyrimidine and triazine kinase inhibitors
Grant 6,943,161 - Erickson , et al. September 13, 2
2005-09-13
N-heterocyclic inhibitors of TNF-.alpha. expression
Grant 6,906,067 - Moriarty , et al. June 14, 2
2005-06-14
Pyrimidine and triazine kinase inhibitors
App 20030149041 - Erickson, Shawn David ;   et al.
2003-08-07
N- heterocyclic inhibitors of TNF-alpha expression
App 20020137747 - Moriarty, Kevin Joseph ;   et al.
2002-09-26
N-heterocyclic inhibitors of TNF-alpha expression
App 20020065270 - Moriarty, Kevin Joseph ;   et al.
2002-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed